{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "multicentre parallel\u2010group randomized clinical trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "a randomized trial of UGFS , EVLA or surgery for varicose veins"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were recruited from 11 UK sites"
      },
      "Intervention": {
        "score": 2,
        "evidence": "comparing ultrasound\u2010guided foam sclerotherapy ( UGFS ), endovenous laser ablation ( EVLA ) and surgery"
      },
      "Objective": {
        "score": 1,
        "evidence": "The aim of this study was to assess behavioural recovery from the patient's perspective"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Patients were followed up 6 weeks after treatment and asked to complete the Behavioural Recovery After treatment for Varicose Veins ( BRAVVO ) questionnaire"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 798 participants were recruited"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "UGFS was superior to EVLA in terms of return to full\u2010time work (hazard ratio 1\u00b743, 95 per cent c.i. 1\u00b711 to 1\u00b785)"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}